4//SEC Filing
RUCH JOSHUA 4
Accession 0000943431-25-000006
CIK 0001818331other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:13 PM ET
Size
29.6 KB
Accession
0000943431-25-000006
Insider Transaction Report
Form 4
RUCH JOSHUA
Director
Transactions
- Sale
Class A Common Stock
2025-11-24$158.40/sh−201$31,839→ 14,644 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$159.28/sh−625$99,547→ 14,019 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$160.45/sh−889$142,640→ 13,130 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$161.16/sh−1,117$180,012→ 12,013 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$162.04/sh−72$11,667→ 11,941 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$158.40/sh−407$64,470→ 29,731 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$159.28/sh−1,268$201,962→ 28,463 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$160.45/sh−1,805$289,611→ 26,658 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$161.16/sh−2,268$365,504→ 24,390 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$162.04/sh−147$23,820→ 24,243 total(indirect: By LLC) - Sale
Class A Common Stock
2025-11-24$158.40/sh−2,016$319,342→ 147,268 total(indirect: VAAL Investment Partners Q9 LP) - Sale
Class A Common Stock
2025-11-24$159.28/sh−6,279$1,000,093→ 140,989 total(indirect: VAAL Investment Partners Q9 LP) - Sale
Class A Common Stock
2025-11-24$160.45/sh−8,944$1,435,059→ 132,045 total(indirect: VAAL Investment Partners Q9 LP) - Sale
Class A Common Stock
2025-11-24$161.16/sh−11,234$1,810,437→ 120,811 total(indirect: VAAL Investment Partners Q9 LP) - Sale
Class A Common Stock
2025-11-24$162.04/sh−728$117,964→ 120,083 total(indirect: VAAL Investment Partners Q9 LP)
Holdings
- 29,723
Class A Common Stock
Footnotes (6)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.80 to $158.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 6 of this Form 4.
- [F2]Mr. Ruch is (i) a managing member of the managing member of the general partner of Vaal Investment Partners Q9 LP ("Q9"), (ii) a managing member of RUGU2 LLC ("RUGU2") and (iii) a managing member of Kariba LLC ("Kariba"). As such, Mr. Ruch exercises voting and investment power with respect to the shares owned by Q9, RUGU2 and Kariba. Mr. Ruch disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.84 to $159.83, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.85 to $160.835, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.85 to $161.84, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.85 to $162.175, inclusive.
Documents
Issuer
GeneDx Holdings Corp.
CIK 0001818331
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0000943431
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:13 PM ET
- Size
- 29.6 KB